Family Medicine Doctors in Goshen, NY Accepting Medicare

9 Family Medicine doctors found. Showing 1 - 9

Elizabeth Owen Zick, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 30 Hatfield Ln, Suite 204, Goshen, NY 10924 Phone: 845-294-6927

Dr. Nicholas D. Belasco, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Hatfield Ln Ste 1b, Goshen, NY 10924 Phone: 845-291-0966    Fax: 845-291-0983

Dr. Jean Mary Hudson, MD, MPH Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 124 Main St, Goshen, NY 10924 Phone: 845-291-2332

John Francis Carey, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 30 Hatfield Ln, Suite 101, Goshen, NY 10924 Phone: 845-294-2733    Fax: 845-294-6486

Zulma Rosado, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 888 Pulaski Hwy, Hudson River Healthcare, Inc., Goshen, NY 10924 Phone: 845-651-2298    Fax: 845-651-2299

Dr. Peter Joseph Cirigliano, DO Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 123 South Church St., Goshen, NY 10924 Phone: 845-615-0929

Dr. Matthew G Rivkin, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 70 Hatfield Ln, Ste 204, Goshen, NY 10924 Phone: 845-291-1260    Fax: 845-294-2312

Rima Reitblat, MD Family Medicine - Geriatric Medicine Medicare: Not Enrolled in Medicare Practice Location: 30 Hatfield Ln, Ste 101, Goshen, NY 10924 Phone: 845-651-1400    Fax: 845-651-1512

Andrew Hirsch, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 30 Hatfield Ln, Suite 101, Goshen, NY 10924 Phone: 845-294-2733    Fax: 845-294-6486

News Archive

Carrot-based Japanese herbal medicine may improve muscle complications associated with COPD

Chronic obstructive pulmonary disease (COPD) is a lung disease caused by long-term inhalation of harmful gases such as cigarette smoke.

Enrolment complete in Veloxis LCP-Tacro Phase III study in de novo kidney transplant patients

Veloxis Pharmaceuticals A/S today announced that enrolment has been completed in its pivotal LCP-Tacro Phase III study in de novo kidney transplant patients. The LCP-Tacro 3002 study is designed to demonstrate non-inferiority versus the gold standard therapy Prograf and has randomized over 540 patients at approximately 90 clinical sites around the world.

Multi-tasking adversely affects brain's learning

Multi-tasking affects the brain's learning systems, and as a result, we do not learn as well when we are distracted, UCLA psychologists report this week in the online edition of Proceedings of the National Academy of Sciences.

Halozyme Therapeutics reports net loss of $9.6 million for first quarter 2011

Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix for the diabetes, cancer, dermatology and drug delivery markets, today reported financial results for the first quarter 2011.

Read more Medical News

› Verified 4 days ago